GTBP Financials

Gt Biopharma Inc - Financial statements & key metrics

Stock Price

$0.73

Market Cap

$7.93M

0

EPS

$-3.50

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

-

Gross Profit

-

Operating Income

-

Net Income

$-13.16M

EPS (Diluted)

$-6.94

Balance Sheet Highlights

Total Assets

$4.23M

Total Liabilities

-

Shareholders Equity

-

Cash & Equivalents

$3.95M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-12.90M

CapEx

-

Free Cash Flow

-

Profitability Metrics

ROE

-3.6%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is GTBP revenue?

View GTBP's income statement for detailed revenue data.

Is GTBP profitable?

GTBP reported a loss of $13.16M in the most recent quarter.

What is GTBP market cap?

GTBP has a market capitalization of $7.93M, making it a small-cap stock.

Does GTBP have debt?

View GTBP's balance sheet for debt information.

What is GTBP cash flow?

Cash flow data is available in the full financial statements.

Explore Categories